FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2800860839> ?p ?o ?g. }

• W2800860839 endingPage "181" @default.
• W2800860839 startingPage "174" @default.
• W2800860839 abstract "Somatic mutations contribute to the heterogeneous prognosis of chronic myelomonocytic leukemia (CMML). Hypomethylating agents (HMAs) are active in CMML, but analyses of small series failed to identify mutations predicting response or survival. We analyzed a retrospective multi-center cohort of 174 CMML patients treated with a median of 7 cycles of azacitidine (n = 68) or decitabine (n = 106). Sequencing data before treatment initiation were available for all patients, from Sanger (n = 68) or next generation (n = 106) sequencing. Overall response rate (ORR) was 52%, including complete response (CR) in 28 patients (17%). In multivariate analysis, ASXL1 mutations predicted a lower ORR (Odds Ratio [OR] = 0.85, p = 0.037), whereas TET2mut/ASXL1wt genotype predicted a higher CR rate (OR = 1.18, p = 0.011) independently of clinical parameters. With a median follow-up of 36.7 months, overall survival (OS) was 23.0 months. In multivariate analysis, RUNX1mut (Hazard Ratio [HR] = 2.00, p = .011), CBLmut (HR = 1.90, p = 0.03) genotypes and higher WBC (log10(WBC) HR = 2.30, p = .005) independently predicted worse OS while the TET2mut/ASXL1wt predicted better OS (HR = 0.60, p = 0.05). CMML-specific scores CPSS and GFM had limited predictive power. Our results stress the need for robust biomarkers of HMA activity in CMML and for novel treatment strategies in patients with myeloproliferative features and RUNX1 mutations." @default.
• W2800860839 created "2018-05-17" @default.
• W2800860839 creator A5001596576 @default.
• W2800860839 creator A5004876764 @default.
• W2800860839 creator A5007247346 @default.
• W2800860839 creator A5007605254 @default.
• W2800860839 creator A5014838075 @default.
• W2800860839 creator A5017578509 @default.
• W2800860839 creator A5018074362 @default.
• W2800860839 creator A5018416096 @default.
• W2800860839 creator A5020739291 @default.
• W2800860839 creator A5022341207 @default.
• W2800860839 creator A5023810956 @default.
• W2800860839 creator A5029369362 @default.
• W2800860839 creator A5040751163 @default.
• W2800860839 creator A5041754278 @default.
• W2800860839 creator A5072463255 @default.
• W2800860839 creator A5075558296 @default.
• W2800860839 creator A5077063317 @default.
• W2800860839 creator A5079124367 @default.
• W2800860839 creator A5088023025 @default.
• W2800860839 creator A5091318797 @default.
• W2800860839 creator A5091358858 @default.
• W2800860839 date "2018-05-01" @default.
• W2800860839 modified "2023-10-17" @default.
• W2800860839 title "Prognostic Role of Gene Mutations in Chronic Myelomonocytic Leukemia Patients Treated With Hypomethylating Agents" @default.
• W2800860839 cites W1548768964 @default.
• W2800860839 cites W1964809738 @default.
• W2800860839 cites W1998931089 @default.
• W2800860839 cites W2016994844 @default.
• W2800860839 cites W2025921758 @default.
• W2800860839 cites W2031657565 @default.
• W2800860839 cites W2037984374 @default.
• W2800860839 cites W2038795176 @default.
• W2800860839 cites W2052505035 @default.
• W2800860839 cites W2062526084 @default.
• W2800860839 cites W2075520330 @default.
• W2800860839 cites W2078786399 @default.
• W2800860839 cites W2080537509 @default.
• W2800860839 cites W2081895311 @default.
• W2800860839 cites W2095066915 @default.
• W2800860839 cites W2127332345 @default.
• W2800860839 cites W2129510594 @default.
• W2800860839 cites W2149089431 @default.
• W2800860839 cites W2191233876 @default.
• W2800860839 cites W2236323615 @default.
• W2800860839 cites W2291640500 @default.
• W2800860839 cites W2465481988 @default.
• W2800860839 cites W2521698020 @default.
• W2800860839 cites W2536035667 @default.
• W2800860839 cites W2549790759 @default.
• W2800860839 cites W2589411765 @default.
• W2800860839 cites W2612520913 @default.
• W2800860839 cites W2617432132 @default.
• W2800860839 cites W2625726302 @default.
• W2800860839 doi "https://doi.org/10.1016/j.ebiom.2018.04.018" @default.
• W2800860839 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6013781" @default.
• W2800860839 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29728305" @default.
• W2800860839 hasPublicationYear "2018" @default.
• W2800860839 type Work @default.
• W2800860839 sameAs 2800860839 @default.
• W2800860839 citedByCount "66" @default.
• W2800860839 countsByYear W28008608392018 @default.
• W2800860839 countsByYear W28008608392019 @default.
• W2800860839 countsByYear W28008608392020 @default.
• W2800860839 countsByYear W28008608392021 @default.
• W2800860839 countsByYear W28008608392022 @default.
• W2800860839 countsByYear W28008608392023 @default.
• W2800860839 crossrefType "journal-article" @default.
• W2800860839 hasAuthorship W2800860839A5001596576 @default.
• W2800860839 hasAuthorship W2800860839A5004876764 @default.
• W2800860839 hasAuthorship W2800860839A5007247346 @default.
• W2800860839 hasAuthorship W2800860839A5007605254 @default.
• W2800860839 hasAuthorship W2800860839A5014838075 @default.
• W2800860839 hasAuthorship W2800860839A5017578509 @default.
• W2800860839 hasAuthorship W2800860839A5018074362 @default.
• W2800860839 hasAuthorship W2800860839A5018416096 @default.
• W2800860839 hasAuthorship W2800860839A5020739291 @default.
• W2800860839 hasAuthorship W2800860839A5022341207 @default.
• W2800860839 hasAuthorship W2800860839A5023810956 @default.
• W2800860839 hasAuthorship W2800860839A5029369362 @default.
• W2800860839 hasAuthorship W2800860839A5040751163 @default.
• W2800860839 hasAuthorship W2800860839A5041754278 @default.
• W2800860839 hasAuthorship W2800860839A5072463255 @default.
• W2800860839 hasAuthorship W2800860839A5075558296 @default.
• W2800860839 hasAuthorship W2800860839A5077063317 @default.
• W2800860839 hasAuthorship W2800860839A5079124367 @default.
• W2800860839 hasAuthorship W2800860839A5088023025 @default.
• W2800860839 hasAuthorship W2800860839A5091318797 @default.
• W2800860839 hasAuthorship W2800860839A5091358858 @default.
• W2800860839 hasBestOaLocation W28008608391 @default.
• W2800860839 hasConcept C104317684 @default.
• W2800860839 hasConcept C126322002 @default.
• W2800860839 hasConcept C143998085 @default.
• W2800860839 hasConcept C150194340 @default.
• W2800860839 hasConcept C156957248 @default.
• W2800860839 hasConcept C190727270 @default.
• W2800860839 hasConcept C207103383 @default.

• next